StemCell Institute Inc.

TSE:7096 Stock Report

Market Cap: JP¥17.1b

StemCell Institute Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Takafumi Shimizu

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8.3yrs
CEO ownership0.5%
Management average tenureno data
Board average tenure5.7yrs

Recent management updates

Recent updates

StemCell Institute Inc. (TSE:7096) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

Aug 05
StemCell Institute Inc. (TSE:7096) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

CEO

Takafumi Shimizu (51 yo)

8.3yrs

Tenure

Mr. Takafumi Shimizu serves as the President and Representative Director at StemCell Institute Inc. since June 2016 and serves as its Chairman.

Board Members

NamePositionTenureCompensationOwnership
Takafumi Shimizu
Chairman & President8.3yrsno data0.50%
¥ 85.8m
Kimihide Ando
Independent Outside Director4.3yrsno data0.039%
¥ 6.7m
Yoshito Fujikawa
Independent Outside Audit & Supervisory Board Member5.7yrsno datano data
Tomoo Yamada
Independent Outside Director5.7yrsno data0.0039%
¥ 667.0k
Ken Nagae
Independent Outside Audit & Supervisory Board Member1.3yrsno datano data

5.7yrs

Average Tenure

63yo

Average Age

Experienced Board: 7096's board of directors are considered experienced (5.7 years average tenure).